VS
Select a second ETF to benchmark against iShares Genomics Immunology and Healthcare Index ETF (XDNA). Compare key metrics including year-to-date performance, management fees, sector exposures and underlying assets to ensure you are selecting the best fund for your investment objectives.
NAV Performance and Flows
Key Data
Compare
XDNA
| AuM | $15.66 M | |
| Management Fees | 0.39% | |
| Exp. ratio | 0.44% | |
| Tracking Difference | -1.01% |
Historical performance and flows
As of September 4, 2026
| 1M | 3M | YTD | 1Y | 3Y | ||
|---|---|---|---|---|---|---|
| Perf. | XDNA | +18.91% | +32.72% | +53.58% | +77.75% | +84.03% |
| Flows | XDNA | +$3 M | +$5 M | +$6 M | +$6 M | +$6 M |
Exposure
Countries
XDNA
USA
60.39%
Germany
8.55%
France
7.33%
Other
23.74%
Sectors
XDNA
Healthcare
99.82%
As of September 4, 2026
Top 10 Holdings
XDNA
Bayer AG
4.77%
Twist Bioscience Corp.
4.73%
Revolution Medicines, Inc.
4.61%
Moderna, Inc.
4.37%
Incyte Corp.
4.30%
Takeda Pharmaceutical Co., Ltd.
4.19%
Regeneron Pharmaceuticals, Inc.
4.16%
Genmab A/S
4.12%
Vertex Pharmaceuticals, Inc.
3.86%
Merck & Co., Inc.
3.85%
Diversification
XDNA
Total weight of top 10 holdings out of 47 total
42.96%
Characteristics
Compare
XDNA
| Provider | iShares | |
| Management | Passively managed | |
| Benchmark | NYSE FactSet Global Genomics and Immuno Biopharma NR Index - CAD | |
| Replication Method | Direct (Physical) | |
| Asset Class | Equity | |
| Dividend Policy | Distributing | |
| Trailing 12m distribution yield | 0.21% | |
| Meets ESG criteria | No | |
| Inception Date | April 26, 2022 |
Recent articles about XDNA
The ETF Market Canada is brought to you by Cboe in partnership with Trackinsight SA who is providing all the data, analysis and editorial content on this site. Unless explicitly stated as such, any information that you receive is not real-time.
All content on the ETF Market Canada is for your general information use only, Cboe is not responsible for any use of content by you outside this scope. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by Cboe and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
All content on the ETF Market Canada is for your general information use only, Cboe is not responsible for any use of content by you outside this scope. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by Cboe and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.